Additionally, research has demonstrated that cytokines are produced by S-protein-reactive T cells on ex vivo antigenic stimulation indicating that they can mediate antiviral response activity and safeguard patients against severe COVID-19, despite the lack of antibodies. This evidence concerns the gene PROS1 and COVID-19.